Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 1/2/3 Study of UX701 Gene Therapy in Adults With Wilson DiseaseBrain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Nutritional and Metabolic Diseases, Wilson disease, basal ganglia disorder, brain disorder, central nervous system disorder, hereditary disease, inborn errors of metabolism, inborn metal metabolism disorder, inherited neurodegenerative disorder, liver disorder, metabolic disease, movement disorder, nervous system disorder, neurodegenerative diseaseActive, not recruitingPhase 1 / Phase 22026-09-25NCT04884815

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Ultragenyx Pharmaceutical Inc24

16 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Centro Hospitalar Universitário de São JoãoPortoPortugal3
Centro Hospitalar Universitário Lisboa NorteLisbonPortugal1
Duke University Medical CenterDurhamUnited States505
Hospital Universitario Vall d'Hebron - PPDSBarcelonaSpain16
Indiana UniversityIndianapolisUnited States160
Kings College NHS FoundationLondonUnited Kingdom1
Massachusetts General HospitalBostonUnited States1015
Northwestern UniversityChicagoUnited States727
Seattle Children's HospitalSeattleUnited States281
Stanford UniversityRedwood CityUnited States25
University Hospitals Cleveland Medical CenterClevelandUnited States234
University of California DavisSacramentoUnited States1
University of California Los AngelesLos AngelesUnited States87
University of MichiganAnn ArborUnited States538
University of UtahSalt Lake CityUnited States106
Vanderbilt University Medical CenterNashvilleUnited States1